Phase II Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil Followed by Weekly Docetaxel and Cetuximab in Concurrence With Intensity-modulated Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma (NPC)
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Complete response rate
Complete response rate is defined as the proportion of subjects with disappearance of all target lesions after induction and concurrent therapies.
Lee Anne W.M., F.R.C.R.(HK)
Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong
Hong Kong: Department of Health